These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 19965518

  • 1. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S, De Stefano N, Amato MP.
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?
    Carmona O, Masuet C, Santiago O, Alía P, Moral E, Alonso-Magdalena L, Casado V, Arbizu T.
    Acta Neurol Scand; 2011 Oct; 124(4):258-63. PubMed ID: 21208197
    [Abstract] [Full Text] [Related]

  • 11. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
    Ramakers IH, Visser PJ, Aalten P, Bekers O, Sleegers K, van Broeckhoven CL, Jolles J, Verhey FR.
    Dement Geriatr Cogn Disord; 2008 Oct; 26(2):101-8. PubMed ID: 18617739
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
    Shi J, Tu JL, Gale SD, Baxter L, Vollmer TL, Campagnolo DI, Tyry TM, Zhuang Y, Kuniyoshi SM.
    Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE, Bläsi S, Berres M, Monsch AU, Stähelin HB, Spiegel R.
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [Abstract] [Full Text] [Related]

  • 19. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, Zipp F, Paul F.
    Neurology; 2009 Nov 17; 73(20):1624-7. PubMed ID: 19917984
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.